PP
PDT Partners’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.17M | Buy |
389,287
+298,989
| +331% | +$2.43M | 0.18% | 200 |
|
|
2025
Q1 | $709K | Sell |
90,298
-35,454
| -28% | -$278K | 0.05% | 461 |
|
|
2024
Q4 | $1.87M | Buy |
125,752
+38,116
| +43% | +$568K | 0.17% | 221 |
|
|
2024
Q3 | $1.34M | Buy |
87,636
+14,371
| +20% | +$220K | 0.12% | 306 |
|
|
2024
Q2 | $1.12M | Sell |
73,265
-23,887
| -25% | -$364K | 0.11% | 315 |
|
|
2024
Q1 | $1.83M | Buy |
97,152
+82,178
| +549% | +$1.55M | 0.17% | 209 |
|
|
2023
Q4 | $286K | Buy |
+14,974
| New | +$286K | 0.03% | 468 |
|
|
2023
Q2 | – | Sell |
-51,925
| Closed | -$947K | – | 637 |
|
|
2023
Q1 | $947K | Buy |
51,925
+13,298
| +34% | +$243K | 0.13% | 275 |
|
|
2022
Q4 | $799K | Sell |
38,627
-19,901
| -34% | -$412K | 0.13% | 292 |
|
|
2022
Q3 | $1.53M | Buy |
58,528
+30,910
| +112% | +$809K | 0.23% | 109 |
|
|
2022
Q2 | $700K | Buy |
+27,618
| New | +$700K | 0.06% | 512 |
|
|
2022
Q1 | – | Sell |
-5,051
| Closed | -$204K | – | 1078 |
|
|
2021
Q4 | $204K | Buy |
+5,051
| New | +$204K | 0.02% | 762 |
|
|
2020
Q4 | – | Sell |
-24,247
| Closed | -$416K | – | 830 |
|
|
2020
Q3 | $416K | Buy |
+24,247
| New | +$416K | 0.03% | 486 |
|
|
2020
Q2 | – | Sell |
-17,033
| Closed | -$236K | – | 793 |
|
|
2020
Q1 | $236K | Sell |
17,033
-2,529
| -13% | -$35K | 0.02% | 526 |
|
|
2019
Q4 | $198K | Sell |
19,562
-3,538
| -15% | -$35.8K | 0.01% | 651 |
|
|
2019
Q3 | $210K | Buy |
23,100
+6,400
| +38% | +$58.2K | 0.01% | 410 |
|
|
2019
Q2 | $133K | Buy |
+16,700
| New | +$133K | 0.01% | 393 |
|